Lexaria Bioscience Corp. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Related Party Transactions

Related Party Transactions

12 Months Ended

Aug. 31, 2020

15.

Related Party Transactions

Management, consulting and accounting services	Cash $		%		Non-Cash⁽²⁾ $		%		Aug 31 2020 Total $		Cash $		%		Non-Cash ⁽²⁾ $		%		Aug 31 2019 Total $
C.A.B Financial Services⁽¹⁾		300,802		66		153,065		34		453,867		223,280		100		—		—	223,280
M&E Services Ltd.⁽¹⁾		121,664		46		143,886		54		265,550		112,377		100		—		—	112,377
Docherty Management Limited⁽¹⁾		242,521		47		275,614		53		518,135		195,740		100		—		—	195,740
Company controlled by a director		—		—		—		—		—		14,932		12		112,718		88	127,650
Directors		67,146		43		88,544		57		155,690		16,138		9		172,330		91	188,468
		732,133				661,109				1,393,242		562,467				285,048			847,515

⁽¹⁾ C.A.B. Financial Services is owned by the CEO of the Company, M&E Services Ltd. is owned by the CFO of the Company, and Docherty Management Limited is owned by the President of the Company.

⁽²⁾ Stock Based Compensation (SBC) and Share Awards are included in the total value of the grants and awards included in expenses. In the year ended August 31, 2020 the Company granted $572,565 of option awards to officers and $88,544 awards to Directors included in Consulting expense replacing cancelled options (Note 13).

Due to related parties:

As at August 31, 2020, $58,704 (August 31, 2019 - $48,096) was payable to related parties included in due to related parties.

The related party transactions are recorded at the exchange amount established and agreed to between the related parties.